Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01997567 · ClinicalTrials.gov registry record · NA
Preemptive Femoral & Lateral Femoral Cutaneous Nerve Blocks for THA Acute Pain
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01997567 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 3 participants.
The verdict
NCT01997567, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The goal of the study is to evaluate via a prospective, blinded, randomized clinical trial, whether ultrasound-guided single femoral and lateral femoral cutaneous nerve blocks with ropivacaine 0.5% with epinephrine (1:200,000) as a tracer for intravascular injection (total 30 ml) vs. saline with epinephrine (1:200,000) (total 30 ml), given just prior to same day elective hip arthroscopy, is effective in reducing acute postoperative pain (NRS scores), postoperative opiate consumption, and time to discharge from the postanesthesia care unit. Differences between groups with respect to postoperative quality of life and functional scores will also be evaluated.
Interventions
- DRUG Placebo
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01997567
The ClinicalTrials.gov registry entry for NCT01997567 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01997567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01997567 about?
NCT01997567 is a clinical study titled "Preemptive Femoral & Lateral Femoral Cutaneous Nerve Blocks for THA Acute Pain". The goal of the study is to evaluate via a prospective, blinded, randomized clinical trial, whether ultrasound-guided single femoral and lateral femoral cutaneous nerve blocks with ropivacaine 0.5% with epinephrine (1:200,000) as a tracer for intravascular injection (total 30 ml) vs. saline with epi...
What is the current status of trial NCT01997567?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-07. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01997567?
The interventions under investigation include: Placebo (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT01997567?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.